|Hazard ratios for survival in diabetic patients with lung cancer based on their use of metformin and/or a TZD, corrected for stage at presentation and age|
|HR (95% CI)||P-value|
|Metformin and/or TZD vs. neither||1.22 (0.96, 1.55)||0.30|
|Metformin alone vs. neither||1.47 (1.12, 1.92)||0.005|
|TZD alone vs. neither||1.04 (0.65, 1.66)||0.87|
Mazzone et al.
Mazzone et al. BMC Cancer 2012 12:410 doi:10.1186/1471-2407-12-410